1,4-Diazabicyclo[2.2.2]octane-1,4-diium-1,4-disulfinate, 95.0%, 250mg

3-methylisoxazolo[5,4-d]pyrimidin-4(5H)-one, 95.0%, 5g

7-Bromo[1,2,4]triazolo[4,3-a]pyridine, 95.0%, 10g

(R)-3-Methyl-piperidine-3-carboxylic acid ethyl ester hydrochloride, 98%, 1g

2-chloro-4-methyl-7,8-dihydro-6H-cyclopenta[g]quinoline, 95.0%, 50g

(R)-5-(Methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid, 95.0%, 5g

2,6-Dimethylheptan-4-amine hydrochloride, 95%, 5g

(R)-6-Methoxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, 95.0%, 25mg

Solución ROTI®Cell Tripsina/EDTA (1x)

{4-fluoro-1-[tris(propan-2-yl)silyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}boronic acid, 97.0%, 250mg

5-Aminooxindole, 95.0%, 1g

Polyethylene Glycol 1100025g

Methyl 4-ethynylbenzoate, 98.0%, 25g